• Pot stocks are soaring again with Tilray surging 50% in premarket trading

    1 month ago - By CNBC

    Tilray's CEO Brendan Kennedy told CNBC that pharmaceutical companies must start thinking about partnering with cannabis producers as a "hedge" against the space.
    Read more ...